Clinical trial
HRT Observational Study of a Mitral Bridge in Patients With Moderate to Severe Mitral Valve Regurgitation to Evaluate Device Safety and Performance
NCT03511716 is registered in ClinicalTrials.gov with Heart Repair Technologies, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- HRT Observational Study of a Mitral Bridge in Patients With Moderate to Severe Mitral Valve Regurgitation to Evaluate Device Safety and Performance
- Lead sponsor
- Heart Repair Technologies, Inc.
- Phase
- Observational
- Overall status
- Terminated
- Start date
- February 6, 2014
- Completion date
- August 31, 2019
- Enrollment
- 34 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
mitral regurgitation